The Department of Internal Medicine has a thriving Research Department under the supervision of Dr. Vidya Menon. The hospital has its own IRB or Internal Review Board and has its own dedicated research assistants assigned for Internal Medicine department alone. Throughout the years, the department makes sure to utilize research activities to further enhance learning of both faculties and residents. During the Pandemic, research and other scholarly activities have thrived very much as the institution participates in different drug trials and studies.
Every year, the Lincoln Medical Center organizes an Annual Research Competition wherein all departments of multiple disciplines participates in showcasing different projects mostly related to patient care.
All residents engaged in research and scholarly activities are given a chance to rotate in a Research Rotation as approved by the Program which is a 2-week dedicated elective time to focus on their research projects and publish their scholarly works. All research and publications are written done by the residents are under supervision of attendings.
The Department/ Residency Program supports residents and faculties in presentation of their works into various societies and conferences.
Recently, the department has received distinction/awards in participating with research activities mostly with residents involvment.
Recent Recognitions- PAGNY Research Awards
2 of our abstracts are selected as part of three top projects to deliver oral presentation on 2020 Research Day and vie for the top prize of $10K! (First prize is 10K, second prize is 5k and 3 rd prize is 2500k)
1)Predictors of Mortality in critically ill patients on mechanical ventilation for COVID-19 infections
2) Short term impact of COVID-19 pandemic in mental and social determinants of health in Ambulatory Care population in South Bronx, a pilot study
Additionally 2 more abstracts have been selected for the 250$ cash reward-
1) Clinical Features, Maternal and Fetal Outcomes in SARS-CoV2 PCR positive pregnant women admitted to a New York City hospital in the Bronx.
2) The Impact of the COVID-19 Pandemic on Burnout, PTSD, Coronavirus Anxiety, and Compassion Fatigue among Staffs at a Hospital in the Bronx
Conferences:
Below are some of our current Research and Scholarly Activities of the year:
Dr. Laverne Yip (PGY1) with mentorship from Dr. Lekshmi Dharmarajan and Dr. Kenneth Ong presented this study and bagged 1st Prize at the 19th Annual Doctor’s Recognition Day Symposium Poster Presentations & Physicians’ Exposition of the Bronx County Medical Society!!!! Congratulations!!
By our PGY3 and aspiring intensivist Dr. Yusuf Mubarak.
Written by our PGY 2: Dr. Maria Angela Matabang for the Renal Fellow Network.
The Baggage of AV Access: Too Big a Load for an Overburdened Heart? – Renal Fellow Network
As of July 2022, Our Drug Trial for Covid has recently been published with the great efforts of our Research department!
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(22)00215-6/fulltext
Great Job! Drs: Iqra Arshad (pgy2), Muhammad Faiz (pgy3), Maria Espejo (Attending, team lead), Masood Shariff.
Awesome work by Dr. Haisum Maqsood (PGY2) and Dr. Muhammad Khalil (PGY2)
Another Publication: By Dr. Bo Yu (RIP), Dr. Yinelka Silverio Castro (PGY2)
Congratulations on the Article for Dr. Edding and the rest of the Research Team https://www.medpagetoday.com/meetingcoverage/nkf/98121
COVID-Related AKI Chronically Hard on Kidneys | MedPage Today
AWESOME JOB by Dr. Kilani (PGY1) and Dr. Laxamana (PGY2) – FRONT PAGE
2021 | Ambulatory Care | Reducing the median length of stay in ExpressCare |
2021 | Ambulatory care | Hypertension control in Primary Care clinic |
Jan-21 | NYCHH/ Rehab | Improving the access to Physical therapy evaluation for Inpatient Medicine patients |
2021 | NYCHH | Assessment of Apprpriateness of Blood Transfusion in Lincoln Hospital |
Jan-21 | NYCHH | SHM FAST Mentored Implementation Program: Facilitating Anticoagulation for Safer Transitions |
2021 | GI | Preventive Care for IBD Patients by optimizing Vaccinations |
2021 | GI | GI referral for NASH |
2021 | GI | Improving Show rate and Quality of Bowel preparation for Patients undergoing Colonoscopy with Colonoscopy App Platform on Cellphones. |
2021 | Pulmonay/ICU | Asthma management and protocols |
2021 | Pulmonary/ICU | Capstone Initiative Title: Improve access for high risk COPD patients to the COPD VIP clinic and Pulmonary Rehabilitation |
2021 | Pulmonary/ICU | Point of Care Ultrasound (POCUS) Training in an Internal Medicine Residency Program – A Quality Improvement Initiative |
2021 | Piulmonary/ICU | Fentanyl use in ICU |
2021 | Pulmonary/ICU | Proper ASA dose 325 mg use in Stroke paients |
2021 | Pulmonary/ICU | Ceribell use in ICU patients and reduction in transfer of ICU patients for suspected status epilepticus |
2021 | Pulmonary/ICU | COVID vaccine in COPD clinic patients |
2021 | Pulmonary/ICU | Door to CT: decreased time for CT done and read in stroke patients |
2021 | Pulmonary/ICU | Documentation of NIHSS in all stroke patients |
2021 | Pulmonary/ICU | Improve compliance with 3 hour and 6 hour bundles in management of severe Sepsis and Septic Shock |
2021 | Palliatve and Hospice | Development and Implementation of a Compassionate Extubation Protocol |
2021 | Palliative and Hospice | Identifying unmet palliative care needs & Improving referrals to palliative care from ambulatory clinic |
2021 | Palliatve and Hospice | Intravenous Ketamine use as a non opiate adjuvant medication for refractory cancer pain policy |
2021 | Palliative and Hospice | Improving quality of life and reducing hospitalizations in patients with advanced cardiopulmonary illnesses by making an early referral for hospice |
2021 | Cardiology | Acute Heart failure management and follow up |
2021 | Cardiology | Chest pain approach protocol |
2021 | HemOnc | Increase referral rate to PM&R for lymphedema education for early management for patients undergoing breast cancer surgery |
2021 | Hospitalist/Hem-Onc | Improving appropriate placement and retrieval of IVC Filters |
2021 | Hospitalist | MD-RN Communication and Motivational Interviewing |
2021 | Hospitalist | Osteoarthritis |
2021 | Hospitalist | Cirrhosis/Ascites management |
2021 | Hospitalist | Effective Consults |
2021 | Hospitalist | Medication Reconciliation |
2021 | Hospitalist | Inpatient Opioid use |
2021 | Hospitalist | Pneumonia management protocol |
2021 | Hospitalist | Inpatient HTN management protocol |
2021 | Hospitalist | BiPAP use |
2021 | Hospitalist/Renal | Hyperkalemia management protocol on the inpatient units |
2021 | Renal | Evaluation of accuracy of diagnosis of MI, 30 days readmission and 6 months mortality after implementation of a standarized workflow for hospitalized ESRD patients with elevated Troponin |
2021 | Renal | Reducing temporary vascular access in ESRD patients |
2021 | Renal | Anemia management in ESRD patients |
2021 | Renal | Nutritional management in ESRD patients |
2021 | Renal | Mineral metabolism disorder management in ESRD patients |
2021 | Endocrinology | Inpatient Diabetes management |
2021 | Endocrinology | Appropriate use of continuous glucose monitoring devices in outpatient setting |
2021 | Infectious Disease | Outpatient Antibiotics use |
2021 | Neurology | Seizure Inpatient management |
2021 | Neurology | ECHO in CVA |
2021 | Rheumatology | 3rd dose Covid vaccination in patients on immunosuppressants |
2021 | Geriatrics | Blood pressure control in elderly |
Ongoing Pharmaceutical: COVID-19
1. Regeneron 2066- A Master protocol assessing the safety, tolerability, and efficacy of anti-spike (S) SARS-CoV2 monoclonal antibodies for thetreatment of hospitalized patients with COVID-19
2. Regeneron 2067- A master protocol for assessing the safety, tolerability, and efficacy of anti-Spike (S) SARS-CoV2 monoclonal antibodies for the treatment of ambulatory patients with COVID-19
3. Regeneron 2069- A Phase 3, randomized, Double blind Placebo controlled Study assessing the efficacy and safety of Anti spike SARS- CoV2 Monoclonal antibodies in preventing SARS-CoV2 infection in household contacts of individuals with SARS- CoV2
4. Gates Foundation– A randomized, controlled, Phase 2b study to evaluate safety and efficacy of rivaroxaban (Xarelto®) for high risk people with mild COVID-19 (Bill & Melinda Gates Medical Research Institute)- Terminated
5. ACTIV-2- A study for Outpatients with COVID-19 (NIH-NIAID)
6. SAGE- Brexenalone in ARDS
7. ACTIV-3– Multicenter, Adaptive, Randomized, Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for Hospitalized Patients with COVID-19
8. Gilead– A Phase 1b/2a Study in Participants with Early Stage COVID-19 to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation
9. REGN 20145– phase 2 study to assess the virologic efficacy of REGN10933+ REGN10987 across different dose regimens in outpatients with SARS-COV-2 infection
10. Roche– A multicenter, phase III randomized, double-blind, placebo-controlled, outpatient study to evaluate the efficacy, safety, and antiviral activity of RO7496998 (AT-527) in patients with mild or moderate covid-19
11. FREEDOM COVID Anticoagulation Strategy Randomized Study
